CLINICAL_TRIALS
research
· 2025-01-15
Clinical Trial Update: Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
Summary
An ongoing clinical study is evaluating whether hepatic-splenic elastography can predict recurrence risk after radiofrequency ablation for hepatocellular carcin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: HCC - Hepatocellular Carcinoma | Status: RECRUITING